PBCJX
Price
$50.39
Change
-$0.42 (-0.83%)
Updated
Sep 5 closing price
Net Assets
11.53B
RGEBX
Price
$82.44
Change
+$0.19 (+0.23%)
Updated
Sep 5 closing price
Net Assets
332.38B
Interact to see
Advertisement

PBCJX vs RGEBX

Header iconPBCJX vs RGEBX Comparison
Open Charts PBCJX vs RGEBXBanner chart's image
Principal Blue Chip J
Price$50.39
Change-$0.42 (-0.83%)
VolumeN/A
Net Assets11.53B
American Funds Growth Fund of Amer R2E
Price$82.44
Change+$0.19 (+0.23%)
VolumeN/A
Net Assets332.38B
PBCJX vs RGEBX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
PBCJX vs. RGEBX commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PBCJX is a Buy and RGEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 332B vs. PBCJX (11.5B). PBCJX (0.00) and RGEBX (0.00) have matching dividends . PBCJX was incepted earlier than RGEBX: PBCJX (8 years) vs RGEBX (11 years). RGEBX (1.09) is less costly to investors than PBCJX (0.80). RGEBX is a more actively managed with annual turnover of: 25.00 vs. PBCJX (14.70). RGEBX has a lower initial minimum investment than PBCJX: RGEBX (250) vs PBCJX (1000). RGEBX annual gain was more profitable for investors over the last year : 17.59 vs. PBCJX (14.19). PBCJX return over 5 years is better than : 51.59 vs. RGEBX (38.71).
PBCJXRGEBXPBCJX / RGEBX
Total Expense Ratio0.771.0971%
Annual Report Gross Expense Ratio0.801.0973%
Fund Existence8 years11 years-
Gain YTD11.18715.39873%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets11.5B332B3%
Annual Yield % from dividends0.000.00-
Returns for 1 year14.1917.5981%
Returns for 3 years69.9557.61121%
Returns for 5 years51.5938.71133%
Returns for 10 yearsN/A91.44-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ARTV3.610.50
+16.08%
Artiva Biotherapeutics Inc
DNLI15.430.64
+4.33%
Denali Therapeutics
FRPH25.47-0.03
-0.12%
FRP Holdings
CNA48.01-0.94
-1.92%
CNA Financial Corp
PMAX0.26-0.03
-9.59%
Powell Max Ltd